316 related articles for article (PubMed ID: 18226173)
21. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.
Yan SF; Ramasamy R; Schmidt AM
J Mol Med (Berl); 2009 Mar; 87(3):235-47. PubMed ID: 19189073
[TBL] [Abstract][Full Text] [Related]
22. The HMGB1 receptor RAGE mediates ischemic brain damage.
Muhammad S; Barakat W; Stoyanov S; Murikinati S; Yang H; Tracey KJ; Bendszus M; Rossetti G; Nawroth PP; Bierhaus A; Schwaninger M
J Neurosci; 2008 Nov; 28(46):12023-12031. PubMed ID: 19005067
[TBL] [Abstract][Full Text] [Related]
23. Signal Diversity of Receptor for Advanced Glycation End Products.
Sakaguchi M; Kinoshita R; Putranto EW; Ruma IMW; Sumardika IW; Youyi C; Tomonobu N; Yamamoto KI; Murata H
Acta Med Okayama; 2017 Dec; 71(6):459-465. PubMed ID: 29276218
[TBL] [Abstract][Full Text] [Related]
24. RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation.
Sparvero LJ; Asafu-Adjei D; Kang R; Tang D; Amin N; Im J; Rutledge R; Lin B; Amoscato AA; Zeh HJ; Lotze MT
J Transl Med; 2009 Mar; 7():17. PubMed ID: 19292913
[TBL] [Abstract][Full Text] [Related]
25. Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes.
Wendt T; Bucciarelli L; Qu W; Lu Y; Yan SF; Stern DM; Schmidt AM
Curr Atheroscler Rep; 2002 May; 4(3):228-37. PubMed ID: 11931721
[TBL] [Abstract][Full Text] [Related]
26. A monoclonal antibody against RAGE alters gene expression and is protective in experimental models of sepsis and pneumococcal pneumonia.
Christaki E; Opal SM; Keith JC; Kessimian N; Palardy JE; Parejo NA; Tan XY; Piche-Nicholas N; Tchistiakova L; Vlasuk GP; Shields KM; Feldman JL; Lavallie ER; Arai M; Mounts W; Pittman DD
Shock; 2011 May; 35(5):492-8. PubMed ID: 21263385
[TBL] [Abstract][Full Text] [Related]
27. Cellular signalling of the receptor for advanced glycation end products (RAGE).
Xie J; Méndez JD; Méndez-Valenzuela V; Aguilar-Hernández MM
Cell Signal; 2013 Nov; 25(11):2185-97. PubMed ID: 23838007
[TBL] [Abstract][Full Text] [Related]
28. RAGE during infectious diseases.
van Zoelen MA; Achouiti A; van der Poll T
Front Biosci (Schol Ed); 2011 Jun; 3(3):1119-32. PubMed ID: 21622260
[TBL] [Abstract][Full Text] [Related]
29. Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases.
Mahajan N; Dhawan V
Int J Cardiol; 2013 Oct; 168(3):1788-94. PubMed ID: 23722052
[TBL] [Abstract][Full Text] [Related]
30. Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications.
Ramasamy R; Yan SF; Schmidt AM
Ann N Y Acad Sci; 2011 Dec; 1243():88-102. PubMed ID: 22211895
[TBL] [Abstract][Full Text] [Related]
31. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
[TBL] [Abstract][Full Text] [Related]
32. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice.
Harja E; Bu DX; Hudson BI; Chang JS; Shen X; Hallam K; Kalea AZ; Lu Y; Rosario RH; Oruganti S; Nikolla Z; Belov D; Lalla E; Ramasamy R; Yan SF; Schmidt AM
J Clin Invest; 2008 Jan; 118(1):183-94. PubMed ID: 18079965
[TBL] [Abstract][Full Text] [Related]
33. RAGE and TLRs: relatives, friends or neighbours?
Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
[TBL] [Abstract][Full Text] [Related]
34. RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model.
Aleshin A; Ananthakrishnan R; Li Q; Rosario R; Lu Y; Qu W; Song F; Bakr S; Szabolcs M; D'Agati V; Liu R; Homma S; Schmidt AM; Yan SF; Ramasamy R
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1823-32. PubMed ID: 18245563
[TBL] [Abstract][Full Text] [Related]
35. Small interfering RNA targeting receptor for advanced glycation end products protects the rats from multibacterial sepsis.
Zhao X; Liao YN; Huang Q
Ir J Med Sci; 2018 Feb; 187(1):225-229. PubMed ID: 28470354
[TBL] [Abstract][Full Text] [Related]
36. RAGE blockade and hepatic microcirculation in experimental endotoxaemic liver failure.
Kuhla A; Norden J; Abshagen K; Menger MD; Vollmar B
Br J Surg; 2013 Aug; 100(9):1229-39. PubMed ID: 23804133
[TBL] [Abstract][Full Text] [Related]
37. Septic shock is associated with receptor for advanced glycation end products ligation of LPS.
Yamamoto Y; Harashima A; Saito H; Tsuneyama K; Munesue S; Motoyoshi S; Han D; Watanabe T; Asano M; Takasawa S; Okamoto H; Shimura S; Karasawa T; Yonekura H; Yamamoto H
J Immunol; 2011 Mar; 186(5):3248-57. PubMed ID: 21270403
[TBL] [Abstract][Full Text] [Related]
38. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.
Schmidt AM; Yan SD; Wautier JL; Stern D
Circ Res; 1999 Mar; 84(5):489-97. PubMed ID: 10082470
[TBL] [Abstract][Full Text] [Related]
39. RAGE: a multi-ligand receptor unveiling novel insights in health and disease.
Alexiou P; Chatzopoulou M; Pegklidou K; Demopoulos VJ
Curr Med Chem; 2010; 17(21):2232-52. PubMed ID: 20459381
[TBL] [Abstract][Full Text] [Related]
40. Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice.
Pusterla T; Nèmeth J; Stein I; Wiechert L; Knigin D; Marhenke S; Longerich T; Kumar V; Arnold B; Vogel A; Bierhaus A; Pikarsky E; Hess J; Angel P
Hepatology; 2013 Jul; 58(1):363-73. PubMed ID: 23504974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
